Cargando…
Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity
Doxorubicin (adriamycin), an anthracycline antibiotic, is commonly used to treat many types of solid and hematological malignancies. Unfortunately, clinical usage of doxorubicin is limited due to the associated acute and chronic cardiotoxicity. Previous studies demonstrated that Astragalus polysacch...
Autores principales: | Cao, Yuan, Shen, Tao, Huang, Xiuqing, Lin, Yajun, Chen, Beidong, Pang, Jing, Li, Guoping, Wang, Que, Zohrabian, Sylvia, Duan, Chao, Ruan, Yang, Man, Yong, Wang, Shu, Li, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341749/ https://www.ncbi.nlm.nih.gov/pubmed/27902477 http://dx.doi.org/10.18632/oncotarget.13596 |
Ejemplares similares
-
Disruption of ROCK1 gene restores autophagic flux and mitigates doxorubicin-induced cardiotoxicity
por: Shi, Jianjian, et al.
Publicado: (2018) -
Astragalus Polysaccharide Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the PI3k/Akt and p38MAPK Pathways
por: Cao, Yuan, et al.
Publicado: (2014) -
miR-488-3p Protects Cardiomyocytes against Doxorubicin-Induced Cardiotoxicity by Inhibiting CyclinG1
por: Yan, Mingjing, et al.
Publicado: (2022) -
Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
por: Chen, De-Shu, et al.
Publicado: (2022) -
Preventing effect of astragalus polysaccharide on cardiotoxicity induced by chemotherapy of epirubicin: A pilot study
por: Li, Xiaofang, et al.
Publicado: (2022)